COMMUNIQUÉS West-GlobeNewswire

Innovation and Value Initiative Rebrands as the Center for Innovation & Value Research

16/07/2024 - 16:00

ALEXANDRIA, Va., July 16, 2024 (GLOBE NEWSWIRE) -- Today, the Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology [...]

Dr. Reed Turpin Joins Center for Oral, Facial & Implant Surgery

16/07/2024 - 15:50

Will Treat Patients in Chattanooga, Cleveland and Fort Oglethorpe CHATTANOOGA, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Reed Turpin, DDS, has joined the Center for Oral, Facial & Implant Surgery as an oral and [...]

For the First Time in the Middle East In-Utero Endoscopic Surgery at KFSHRC Corrects Spinal Cord Defect in 26-Week-Old Fetus

16/07/2024 - 15:36

RIYADH, Saudi Arabia, July 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh successfully performed life-changing surgery on a 26-week-old fetus correcting a [...]

Nymox Required to Resubmit Application to DKMA

16/07/2024 - 15:30

IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its MAA submission to the Danish Medicines Agency (DKMA) has run out of time and in [...]

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to SLS009 for the Treatment of Pediatric Acute Myeloid Leukemia

16/07/2024 - 15:05

- Acute Myeloid Leukemia (AML) is the Second Most Common Hematological Malignancy in Children Often Associated with Poorer Prognosis Compared to Other Pediatric Cancers – - This Recognition Marks SELLAS’ Second RPDD [...]

Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism

16/07/2024 - 15:02

Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Anosh Inc. Foundation Reflects on a Year of Transformative Impact in 2023

16/07/2024 - 15:01

Anosh Inc. Foundation marks a year of pivotal support and charity, uplifting communities through significant donations and active involvement CHICAGO, July 16, 2024 (GLOBE NEWSWIRE) -- As we reach the midpoint of 2024, [...]

Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer

16/07/2024 - 15:00

Accomplished cultural transformation leader brings extensive company-building expertise CAMBRIDGE, Mass, July 16, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Tamara Dillon has joined the [...]

FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)

16/07/2024 - 15:00

Investigational New Drug (IND) application to be filed in the fourth quarter of 2024 Phase 1 clinical trial in children with DIPG to be initiated in early 2025 RALEIGH, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- FLAG [...]

RosenCare and PeopleOne Health Join Forces to Transform Healthcare Market in Florida

16/07/2024 - 15:00

New partnership aims to deliver exceptional primary care to millions of people in the region PITTSBURGH and ORLANDO, Fla., July 16, 2024 (GLOBE NEWSWIRE) -- RosenCare , a premier healthcare provider known for its [...]

The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello

16/07/2024 - 14:45

STUDIO CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members, Myeloma Support Group Leader Jack [...]

Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis

16/07/2024 - 14:37

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and [...]

Senti Bio Announces Reverse Stock Split

16/07/2024 - 14:30

Shares expected to begin trading on split-adjusted basis on July 18, 2024 SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”) , a biotechnology company [...]

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

16/07/2024 - 14:30

Reimbursement expected to accelerate medical site activations and cover a portion of the Company’s NEUTRALIZE-AKI trial costs DENVER, July 16, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), [...]

Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada

16/07/2024 - 14:30

July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical [...]

EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation

15/07/2024 - 18:00

Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]

Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas

15/07/2024 - 17:57

DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera BioSolutions, a [...]

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

15/07/2024 - 16:29

Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- Sabin Vaccine Institute launched a [...]

SoldierStrong Marks 15ᵗʰ Anniversary With Focus on New Approaches to Help Veterans Take Their Next Steps Forward

15/07/2024 - 16:00

STAMFORD, Conn., July 15, 2024 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit group committed to donating revolutionary medical technology to improve the lives of injured veterans, marks its 15 th anniversary today with [...]